Business
IBA signs contract for a Proteus®ONE proton therapy system to be located at the MacKay Memorial Hospital in New Taipei City, Taiwan
Louvain-La-Neuve, Belgium, January 27, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the supply of a Proteus®ONE1 compact proton therapy solution to be installed at the MacKay Memorial Hospital in New Taipei City, Taiwan. This is the fourth order of a Proteus®ONE system in Taiwan, further reinforcing IBA’s
About this update from Ion Beam Applications Sa
[{"type":"image","alt":"IBA SA","displaySize":"","headline":null,"caption":"IBA SA","className":"","disableSlideshowImg":false,"size":{"original":{"width":85,"height":85,"url":"https://media.zenfs.com/en/globenewswire.com/ab9cb8d53c1f491c2297f1d9274f5694"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Z4qZvB1n65el3DgzVQJgKA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTExMDtoPTExMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ab9cb8d53c1f491c2297f1d9274f5694","width":85,"height":85}},"lazy":false},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"Louvain-La-Neuve, Belgium, January 27, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the supply of a Proteus®ONE1 compact proton therapy solution to be installed at the MacKay Memorial Hospital in New Taipei City, Taiwan. This is the fourth order of a Proteus®ONE system in Taiwan, further reinforcing IBA’s position as the undisputed market leader.","length":541,"tagName":"p"},{"type":"text","content":"The contract includes the delivery and the installation of a Proteus®ONE system as well as a comprehensive Quality Assurance package from IBA Dosimetry. As the market-leading compact proton therapy system, Proteus®ONE is designed to evolve and incorporate the latest technological advancements, ensuring that IBA users continue to benefit from state-of-the-art innovation. The system will also feature DynamicARC®2 beam delivery capabilities, pending regulatory clearance. MacKay Memorial Hospital expects to start treating patients in 2029.","length":546,"tagName":"p"},{"type":"text","content":"Olivier Legrain, Chief Executive Officer of IBA, commented: “We are delighted to secure this new Proteus®ONE contract, the second in Taiwan in less than a year. The growing interest in our proton therapy solutions across Asia is a testament to the strength of our innovation strategy and our commitment to close partnerships. This success further consolidates IBA’s position as the undisputed leader in the global proton therapy market and demonstrates our dedication to making this cutting-edge technology accessible to more patients worldwide. We look forward to working closely with the MacKay Memorial Hospital te...